U.S. Dental Bone Graft Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF U.S. DENTAL BONE GRAFT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET APPLICATION COVERAGE GRID

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 CLIMATE CHANGE SCENARIO–

4.2.1 INTRODUCTION

4.2.2 ENVIRONMENTAL CONCERNS

4.2.3 INDUSTRY RESPONSE

4.2.4 GOVERNMENT’S ROLE

4.2.5 ANALYST RECOMMENDATIONS

4.2.6 CONCLUSION

4.3 COST ANALYSIS BREAKDOWN–

4.3.1 INTRODUCTION

4.3.2 PRODUCTION COST ANALYSIS

4.3.2.1 RAW MATERIAL PROCUREMENT

4.3.2.2 MANUFACTURING & PROCESSING

4.3.2.3 REGULATORY COMPLIANCE & QUALITY ASSURANCE

4.3.3 DISTRIBUTION COST ANALYSIS

4.3.3.1 LOGISTICS & STORAGE

4.3.3.2 SUPPLY CHAIN INTERMEDIARIES

4.3.3.3 INVENTORY MANAGEMENT

4.3.4 COMMERCIAL PRICING DYNAMICS

4.3.4.1 PRICING STRATEGY & LIST PRICE DETERMINATION

4.3.4.2 INSURANCE & REIMBURSEMENT INFLUENCE

4.3.4.3 MARKET COMPETITION & CONTRACT PRICING

4.3.5 CONCLUSION

4.4 INDUSTRY ECOSYSTEM ANALYSIS

4.4.1 INTRODUCTION

4.4.2 PROMINENT COMPANIES

4.4.3 SMALL & MEDIUM SIZE COMPANIES

4.4.4 END USERS

4.4.5 CONCLUSION

4.5 INNOVATION TRACKER AND STRATEGIC ANALYSIS

4.5.1 INTRODUCTION

4.5.2 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS

4.5.2.1 JOINT VENTURES

4.5.2.2 MERGERS AND ACQUISITIONS

4.5.2.3 LICENSING AND PARTNERSHIP’

4.5.2.4 TECHNOLOGY COLLABORATIONS

4.5.2.5 STRATEGIC DIVESTMENTS

4.5.3 NUMBER OF PRODUCTS IN DEVELOPMENT

4.5.4 STAGE OF DEVELOPMENT

4.5.5 TIMELINES AND MILESTONES

4.5.6 INNOVATION STRATEGIES AND METHODOLOGIES

4.5.7 RISK ASSESSMENT AND MITIGATION

4.5.8 FUTURE OUTLOOK

4.5.9 CONCLUSION

4.6 NUMBER OF PROCEDURES-

4.6.1 TOTAL NUMBER OF DENTAL BONE GRAFT PROCEDURES FOR DENTAL IMPLANT PLACEMENT

4.6.2 NUMBER OF EXTRACTION SOCKET GRAFTING PROCEDURES

4.6.3 NUMBER OF SINUS LIFT PROCEDURES

4.6.4 NUMBER OF VERTICAL AND/OR LATERAL RIDGE AUGMENTATION PROCEDURES

4.6.5 OTHER RELEVANT DENTAL BONE GRAFTING PROCEDURE DATA

4.7 PATENT ANALYSIS–

4.7.1 INTRODUCTION

4.7.2 PATENT QUALITY AND STRENGTH

4.7.3 PATENT FAMILIES

4.7.4 LICENSING AND COLLABORATIONS

4.7.5 REGIONAL PATENT LANDSCAPE

4.7.6 IP STRATEGY AND MANAGEMENT

4.7.7 CONCLUSION

4.8 RAW MATERIAL COVERAGE

4.8.1 SYNTHETIC BONE GRAFTS

4.8.2 NATURAL BONE GRAFTS

4.8.3 CELL-BASED AND GROWTH FACTOR ENHANCEMENTS

4.9 BRAND OUTLOOK

4.1 VENDOR SELECTION CRITERIA

4.10.1 REGULATORY & COMPLIANCE CREDENTIALS

4.10.2 CLINICAL PERFORMANCE & EVIDENCE

4.10.3 MATERIAL QUALITY & TRACEABILITY

4.10.4 RANGE & CUSTOMIZATION OF PRODUCT PORTFOLIO

4.10.5 QUALITY ASSURANCE & MANUFACTURING STANDARDS

4.10.6 SUPPLY CHAIN RELIABILITY & LOGISTICS

4.10.7 COMMERCIAL VALUE & PRICING STRUCTURE

4.10.8 SUPPORT SERVICES & TRAINING

4.10.9 REPUTATION & MARKET PRESENCE

4.10.10 POST‑PURCHASE SUPPORT & WARRANTY

4.10.11 SUMMARY OF KEY CATEGORIES FOR U.S. VENDOR SELECTION CRITERIA:

4.11 TECHNOLOGICAL ADVANCEMENTS

4.11.1 OVERVIEW

4.11.2 3D IMAGING AND TREATMENT PLANNING

4.11.3 GROWTH FACTORS AND STEM CELL THERAPY

4.11.4 BONE GRAFTING WITH PLATELET-RICH PLASMA (PRP)

4.11.5 INNOVATIVE BONE GRAFTING TECHNIQUES

4.11.6 CUTTING-EDGE GRAFTING MATERIALS

4.11.7 IMPLICATIONS FOR PATIENTS:

4.11.8 SUMMARY:

4.12 PRICING ANALYSIS

4.12.1 INTRODUCTION

4.12.2 NATURAL BONE GRAFT (ALLOGRAFTS & XENOGRAFTS)

4.12.3 SYNTHETIC BONE GRAFT

4.12.4 GROWTH FACTORS (E.G., RHBMP-2 BASED PRODUCTS)

4.12.5 LIVE OSTEOGENIC CELLS BONE SUBSTITUTES (CELLULAR BONE MATRICES)

4.12.6 OTHERS (COLLAGEN MEMBRANES, COMBINATION KITS, PUTTY CARRIERS)

4.12.7 CONCLUSION

4.13 PROFIT MARGINS SCENARIO

4.13.1 INTRODUCTION

4.13.2 GROSS MARGIN STRUCTURE AND COST ARCHITECTURE

4.13.3 PRICING STRATEGY AND VALUE-BASED MARGIN PRESERVATION

4.13.4 REGULATORY COMPLIANCE AND ITS INFLUENCE ON OPERATING MARGINS

4.13.5 DISTRIBUTION ECONOMICS AND NET PROFIT REALIZATION

4.13.6 COMPETITIVE LANDSCAPE AND LONG-TERM MARGIN SUSTAINABILITY

4.13.7 CONCLUSION

4.14 SUPPLY CHAIN ANALYSIS –

4.14.1 INTRODUCTION

4.14.2 RAW INPUT SOURCING & PROCUREMENT

4.14.3 PROCESSING & PRODUCT MANUFACTURING (PRODUCTION)

4.14.4 SUPPLY CHAIN & DISTRIBUTION LOGISTICS (TRANSPORTATION)

4.14.5 RETAIL & COMMERCIAL BUYER CHANNELS (DISTRIBUTION & SALES)

4.14.6 CONCLUSION

4.15 VALUE CHAIN ANALYSIS

4.15.1 INBOUND LOGISTICS

4.15.2 OPERATIONS

4.15.3 OUTBOUND LOGISTICS

4.15.4 MARKETING AND SALES

4.15.5 AFTER-SALES SERVICE

5 TARIFFS & IMPACT–

5.1 INTRODUCTION

5.2 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE

5.3 VENDOR SELECTION CRITERIA DYNAMICS

5.4 IMPACT ON SUPPLY CHAIN

5.4.1 RAW MATERIAL PROCUREMENT

5.4.2 MANUFACTURING AND PRODUCTION

5.4.3 LOGISTICS AND DISTRIBUTION

5.4.4 PRICE PITCHING AND POSITION OF MARKET

5.5 INDUSTRY PARTICIPANTS: PROACTIVE MOVES

5.5.1 SUPPLY CHAIN OPTIMIZATION

5.5.2 JOINT VENTURE ESTABLISHMENTS

5.6 IMPACT ON PRICES

5.7 REGULATORY INCLINATION

5.7.1 GEOPOLITICAL SITUATION

5.7.2 TRADE PARTNERSHIPS BETWEEN THE COUNTRIES

5.7.2.1 FREE TRADE AGREEMENTS

5.7.2.2 ALLIANCE ESTABLISHMENTS

5.7.2.3 STATUS ACCREDITATION (INCLUDING MFN)

5.7.3 DOMESTIC COURSE OF CORRECTION

5.7.3.1 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS

5.7.3.2 ESTABLISHMENT OF SPECIAL ECONOMIC ZONES / INDUSTRIAL PARKS

5.8 CONCLUSION

6 REGULATION COVERAGE–

6.1 INTRODUCTION

6.2 PRODUCT CODES

6.2.1 CERTIFIED STANDARDS

6.3 SAFETY STANDARDS

6.3.1 MATERIAL HANDLING & STORAGE

6.3.2 TRANSPORT & PRECAUTIONS

6.3.3 HAZARD IDENTIFICATION

6.4 CONCLUSION

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 SUSTAINED INCREASE IN IMPLANT-DRIVEN BONE AUGMENTATION PROCEDURES ACROSS THE U.S.

7.1.2 CLINICALLY EMBEDDED REGENERATIVE TREATMENT PLANNING IN PERIODONTAL CARE.

7.1.3 STRONG ACCEPTANCE OF SYNTHETIC AND XENOGRAFT MATERIALS AMONG U.S. CLINICIANS

7.1.4 EXPANDING GERIATRIC POPULATION SEEKING FUNCTIONAL AND AESTHETIC REHABILITATION

7.2 RESTRAINTS

7.2.1 HIGH PATIENT COST BURDEN DUE TO LIMITED INSURANCE COVERAGE.

7.2.2 CLINICAL OUTCOME VARIABILITY AND TECHNIQUE SENSITIVITY

7.3 OPPORTUNITIES

7.3.1 DEVELOPMENT OF BIOACTIVE AND OSTEOINDUCTIVE ENHANCED MATERIALS

7.3.2 EXPANSION THROUGH DENTAL SERVICE ORGANIZATION (DSO) PROCUREMENT NETWORKS

7.3.3 INCREASING ADOPTION OF MINIMALLY INVASIVE REGENERATIVE TECHNIQUES

7.4 CHALLENGES

7.4.1 STRINGENT REGULATORY AND CLINICAL VALIDATION REQUIREMENTS

7.4.2 INTENSIFYING PRICING PRESSURE FROM ESTABLISHED AND VALUE-BASED COMPETITORS

8 U.S. DENTAL BONE GRAFT MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 NATURAL BONE GRAFT

8.2.1 U.S. NATURAL BONE GRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.2.1.1 XENOGRAFT

8.2.1.1.1 U.S. XENOGRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.2.1.1.1.1 BOVINE-DERIVED

8.2.1.1.1.2 PORCINE-DERIVED

8.2.1.1.1.3 CHITOSAN DERIVED

8.2.1.1.1.4 OTHERS

8.2.1.2 ALLOGRAFT

8.2.1.2.1 U.S. ALLOGRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.2.1.2.1.1 FRESH OR FRESH-FROZEN BONE

8.2.1.2.1.2 U.S. FRESH OR FRESH-FROZEN BONE IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.2.1.2.1.3 DEMINERALISED BONE ALLOGRAFT

8.2.1.2.1.4 OCELLULAR BONE ALLOGRAFTS

8.2.1.2.1.5 MACHINED ALLOGRAFTS

8.2.1.2.1.6 U.S. FRESH OR FRESH-FROZEN BONE IN DENTAL BONE GRAFT MARKET, BY USABILITY, 2018-2033 (USD THOUSAND)

8.2.1.2.1.7 BIO-REABSORBABLE

8.2.1.2.1.8 NON BIO-REABSORBABLE

8.2.1.2.1.9 FREEZE DRIED BONE ALLOGRAFT (FDBA)

8.2.1.2.1.10 U.S. FREEZE DRIED BONE ALLOGRAFT (FDBA) IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.2.1.2.1.11 DEMINERALISED BONE ALLOGRAFT

8.2.1.2.1.12 OCELLULAR BONE ALLOGRAFTS

8.2.1.2.1.13 MACHINED ALLOGRAFTS

8.2.1.2.1.14 U.S. FREEZE DRIED BONE ALLOGRAFT (FDBA) IN DENTAL BONE GRAFT MARKET, BY USABILITY, 2018-2033 (USD THOUSAND)

8.2.1.2.1.15 BIO-REABSORBABLE

8.2.1.2.1.16 NON BIO-REABSORBABLE

8.2.1.3 AUTOGRAFTS

8.2.1.3.1 U.S. AUTOGRAFTS IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.2.1.3.1.1 MANDIBULAR SYMPHYSIS

8.2.1.3.1.2 MANDIBULAR RAMUS

8.2.1.3.1.3 ILIAC CREST

8.2.1.3.1.4 EXTERNAL OBLIQUE RIDGE

8.2.1.3.1.5 PROXIMAL ULNA

8.2.1.3.1.6 DISTAL RADIUS

8.2.1.4 PHYTOGENIC MATERIALS

8.2.1.4.1 U.S. PHYTOGENIC MATERIALS IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.2.1.4.1.1 CORAL-BASED BONE SUBSTITUTES

8.2.1.4.1.2 MARINE ALGAE

8.2.1.4.1.3 GUSUBU

8.3 SYNTHETIC BONE GRAFT

8.3.1 U.S. SYNTHETIC BONE GRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.3.2 TRICALCIUM PHOSPHATE CERAMICS

8.3.3 HYDROXYAPATITE

8.3.4 BIPHASIC CALCIUM PHOSPHATE CERAMICS

8.3.5 BIOACTIVE GLASS

8.3.6 POLYMERS

8.3.6.1 U.S. POLYMERS IN DENTAL BONE GRAFT MARKET, BY USABILITY, 2018-2033 (USD THOUSAND)

8.3.6.1.1 DEGRADABLE

8.3.6.1.2 NON-DEGRADABLE

8.3.6.2 U.S. POLYMERS IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.3.6.2.1 POLYLACTIC ACID

8.3.6.2.2 POLY-Ε-CAPROLACTONE

8.3.6.2.3 POLYGLYCOLIC ACID

8.3.6.2.4 OTHERS

8.3.7 CALCIUM PHOSPHATE CEMENT

8.3.8 CALCIUM-PHOSPHOSILICATE

8.3.9 COMPOSITES

8.3.9.1 U.S. COMPOSITES IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.3.9.1.1 NANOCRYSTALLINE HA/SILICON DIOXIDE

8.3.9.1.2 Β-TCP/CALCIUM SULPHATE

8.3.10 METALS

8.3.10.1 U.S. METALS IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.3.10.1.1 MAGNESIUM (MG)

8.3.10.1.2 STRONTIUM (SR)

8.3.10.1.3 ZINC (ZN)

8.3.10.1.4 SILICON (SI)

8.4 GROWTH FACTORS

8.4.1 U.S. GROWTH FACTORS IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.4.1.1 BONE MORPHOGENETIC PROTEIN (BMP)

8.4.1.2 PLATELET-DERIVED GROWTH FACTOR (PDGF)

8.4.1.3 TRANSFORMING GROWTH FACTOR-BETA (TGF-BETA)

8.4.1.4 FIBROBLAST GROWTH FACTORS (FGF)

8.5 LIVE OSTEOGENIC CELLS BONE SUBSTITUTES

8.5.1 U.S. LIVE OSTEOGENIC CELLS BONE SUBSTITUTES IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.5.1.1 OSTEOTRANSPLANT DENT

8.5.1.2 BIOSEED-ORAL BONE

8.6 OTHERS

9 U.S. DENTAL BONE GRAFT MARKET, BY BRAND

9.1 OVERVIEW

9.2 BIO OSS

9.3 GRAFTON

9.4 CERABONE

9.5 PERIOGLAS

9.6 ENDOBON

9.7 OSTEOGRAF

9.8 MASTERGRAFT

9.9 OTHERS

10 U.S. DENTAL BONE GRAFT MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 IMPLANT BONE REGENERATION

10.2.1 U.S. IMPLANT BONE REGENERATION IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.2.1.1 NATURAL BONE GRAFT

10.2.1.1.1 U.S. NATURAL BONE GRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.2.1.1.1.1 XENOGRAFT

10.2.1.1.1.2 ALLOGRAFT

10.2.1.1.1.3 AUTOGRAFTS

10.2.1.1.1.4 PHYTOGENIC MATERIALS

10.2.1.2 SYNTHETIC BONE GRAFT

10.2.1.2.1 U.S. SYNTHETIC BONE GRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.2.1.2.1.1 TRICALCIUM PHOSPHATE CERAMICS

10.2.1.2.1.2 HYDROXYAPATITE

10.2.1.2.1.3 BIPHASIC CALCIUM PHOSPHATE CERAMICS

10.2.1.2.1.4 BIOACTIVE GLASS

10.2.1.2.1.5 POLYMERS

10.2.1.2.1.6 CALCIUM PHOSPHATE CEMENT

10.2.1.2.1.7 CALCIUM-PHOSPHOSILICATE

10.2.1.2.1.8 COMPOSITES

10.2.1.2.1.9 METALS

10.2.1.3 GROWTH FACTORS

10.2.1.4 LIVE OSTEOGENIC CELLS BONE SUBSTITUTES

10.2.1.5 OTHERS

10.3 RIDGE AUGMENTATION

10.3.1 U.S. RIDGE AUGMENTATION IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.3.1.1 NATURAL BONE GRAFT

10.3.1.1.1 U.S. NATURAL BONE GRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.3.1.1.1.1 XENOGRAFT

10.3.1.1.1.2 ALLOGRAFT

10.3.1.1.1.3 AUTOGRAFTS

10.3.1.1.1.4 PHYTOGENIC MATERIALS

10.3.1.2 SYNTHETIC BONE GRAFT

10.3.1.2.1 U.S. SYNTHETIC BONE GRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.3.1.2.1.1 TRICALCIUM PHOSPHATE CERAMICS

10.3.1.2.1.2 HYDROXYAPATITE

10.3.1.2.1.3 BIPHASIC CALCIUM PHOSPHATE CERAMICS

10.3.1.2.1.4 BIOACTIVE GLASS

10.3.1.2.1.5 POLYMERS

10.3.1.2.1.6 CALCIUM PHOSPHATE CEMENT

10.3.1.2.1.7 CALCIUM-PHOSPHOSILICATE

10.3.1.2.1.8 COMPOSITES

10.3.1.2.1.9 METALS

10.3.1.3 GROWTH FACTORS

10.3.1.4 LIVE OSTEOGENIC CELLS BONE SUBSTITUTES

10.3.1.5 OTHERS

10.4 SOCKET PRESERVATION

10.4.1 U.S. SOCKET PRESERVATION IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.4.1.1 NATURAL BONE GRAFT

10.4.1.1.1 U.S. NATURAL BONE GRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.4.1.1.1.1 XENOGRAFT

10.4.1.1.1.2 ALLOGRAFT

10.4.1.1.1.3 AUTOGRAFTS

10.4.1.1.1.4 PHYTOGENIC MATERIALS

10.4.1.2 SYNTHETIC BONE GRAFT

10.4.1.2.1 U.S. SYNTHETIC BONE GRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.4.1.2.1.1 TRICALCIUM PHOSPHATE CERAMICS

10.4.1.2.1.2 HYDROXYAPATITE

10.4.1.2.1.3 BIPHASIC CALCIUM PHOSPHATE CERAMICS

10.4.1.2.1.4 BIOACTIVE GLASS

10.4.1.2.1.5 POLYMERS

10.4.1.2.1.6 CALCIUM PHOSPHATE CEMENT

10.4.1.2.1.7 CALCIUM-PHOSPHOSILICATE

10.4.1.2.1.8 COMPOSITES

10.4.1.2.1.9 METALS

10.4.1.3 GROWTH FACTORS

10.4.1.4 LIVE OSTEOGENIC CELLS BONE SUBSTITUTES

10.4.1.5 OTHERS

10.5 PERIODONTAL DEFECT REGENERATION

10.5.1 U.S. PERIODONTAL DEFECT REGENERATION IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.5.1.1 NATURAL BONE GRAFT

10.5.1.1.1 U.S. NATURAL BONE GRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.5.1.1.1.1 XENOGRAFT

10.5.1.1.1.2 ALLOGRAFT

10.5.1.1.1.3 AUTOGRAFTS

10.5.1.1.1.4 PHYTOGENIC MATERIALS

10.5.1.2 SYNTHETIC BONE GRAFT

10.5.1.2.1 U.S. SYNTHETIC BONE GRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.5.1.2.1.1 TRICALCIUM PHOSPHATE CERAMICS

10.5.1.2.1.2 HYDROXYAPATITE

10.5.1.2.1.3 BIPHASIC CALCIUM PHOSPHATE CERAMICS

10.5.1.2.1.4 BIOACTIVE GLASS

10.5.1.2.1.5 POLYMERS

10.5.1.2.1.6 CALCIUM PHOSPHATE CEMENT

10.5.1.2.1.7 CALCIUM-PHOSPHOSILICATE

10.5.1.2.1.8 COMPOSITES

10.5.1.2.1.9 METALS

10.5.1.3 GROWTH FACTORS

10.5.1.4 LIVE OSTEOGENIC CELLS BONE SUBSTITUTES

10.5.1.5 OTHERS

10.6 SINUS LIFT

10.6.1 U.S. SINUS LIFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.6.1.1 NATURAL BONE GRAFT

10.6.1.1.1 U.S. NATURAL BONE GRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.6.1.1.1.1 XENOGRAFT

10.6.1.1.1.2 ALLOGRAFT

10.6.1.1.1.3 AUTOGRAFTS

10.6.1.1.1.4 PHYTOGENIC MATERIALS

10.6.1.2 SYNTHETIC BONE GRAFT

10.6.1.2.1 U.S. SYNTHETIC BONE GRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.6.1.2.1.1 TRICALCIUM PHOSPHATE CERAMICS

10.6.1.2.1.2 HYDROXYAPATITE

10.6.1.2.1.3 BIPHASIC CALCIUM PHOSPHATE CERAMICS

10.6.1.2.1.4 BIOACTIVE GLASS

10.6.1.2.1.5 POLYMERS

10.6.1.2.1.6 CALCIUM PHOSPHATE CEMENT

10.6.1.2.1.7 CALCIUM-PHOSPHOSILICATE

10.6.1.2.1.8 COMPOSITES

10.6.1.2.1.9 METALS

10.6.1.3 GROWTH FACTORS

10.6.1.4 LIVE OSTEOGENIC CELLS BONE SUBSTITUTES

10.6.1.5 OTHERS

10.7 OTHERS

10.7.1 U.S. OTHERS IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.7.1.1 NATURAL BONE GRAFT

10.7.1.1.1 U.S. NATURAL BONE GRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.7.1.1.1.1 XENOGRAFT

10.7.1.1.1.2 ALLOGRAFT

10.7.1.1.1.3 AUTOGRAFTS

10.7.1.1.1.4 PHYTOGENIC MATERIALS

10.7.1.2 SYNTHETIC BONE GRAFT

10.7.1.2.1 U.S. SYNTHETIC BONE GRAFT IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.7.1.2.1.1 TRICALCIUM PHOSPHATE CERAMICS

10.7.1.2.1.2 HYDROXYAPATITE

10.7.1.2.1.3 BIPHASIC CALCIUM PHOSPHATE CERAMICS

10.7.1.2.1.4 BIOACTIVE GLASS

10.7.1.2.1.5 POLYMERS

10.7.1.2.1.6 CALCIUM PHOSPHATE CEMENT

10.7.1.2.1.7 CALCIUM-PHOSPHOSILICATE

10.7.1.2.1.8 COMPOSITES

10.7.1.2.1.9 METALS

10.7.1.3 GROWTH FACTORS

10.7.1.4 LIVE OSTEOGENIC CELLS BONE SUBSTITUTES

10.7.1.5 OTHERS

11 U.S. DENTAL BONE GRAFT MARKET, BY USAGE

11.1 OVERVIEW

11.2 BONE GRAFT SUBSTITUTES

11.2.1 U.S. BONE GRAFT SUBSTITUTES IN DENTAL BONE GRAFT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)

11.2.1.1 NATURAL

11.2.1.1.1 U.S. NATURAL IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

11.2.1.1.1.1 XENOGRAFT

11.2.1.1.1.2 ALLOGRAFT

11.2.1.1.1.3 AUTOGRAFTS

11.2.1.1.1.4 PHYTOGENIC MATERIALS

11.2.1.2 SYNTHETIC

11.2.1.3 OTHERS

11.3 BONE GRAFT EXTENDERS

11.3.1 U.S. BONE GRAFT EXTENDERS IN DENTAL BONE GRAFT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

11.3.1.1 TRICALCIUM PHOSPHATE CERAMICS

11.3.1.2 HYDROXYAPATITE

11.3.1.3 BIOACTIVE GLASS

11.3.1.4 BIPHASIC CALCIUM PHOSPHATE CERAMICS

11.3.1.5 CALCIUM PHOSPHATE CEMENT

11.3.1.6 CALCIUM-PHOSPHOSILICATE

11.3.1.7 POLYMERS

11.3.1.8 OTHERS

12 U.S. DENTAL BONE GRAFT MARKET, BY MECHANISM

12.1 OVERVIEW

12.2 OSTEOCONDUCTION

12.3 OSTEOINDUCTION

12.4 OSTEOPROMOTION

12.5 OSTEOGENESIS

13 U.S. DENTAL BONE GRAFT MARKET, BY MATERIAL FORM

13.1 OVERVIEW

13.2 GRANULES

13.3 PUTTY

13.4 INJECTABLES

14 U.S. DENTAL BONE GRAFT MARKET, BY AGE

14.1 OVERVIEW

14.2 ADULT

14.3 GERIATRIC

14.4 PEDIATRICS

15 U.S. DENTAL BONE GRAFT MARKET, BY POPULATION

15.1 OVERVIEW

15.2 FEMALE

15.3 MALE

16 U.S. DENTAL BONE GRAFT MARKET, BY END USER

16.1 OVERVIEW

16.2 DENTAL CLINICS

16.3 HOSPITALS

16.4 RESEARCH AND DENTAL LABORATORIES

16.5 OTHERS

17 U.S. DENTAL BONE GRAFT MARKET, BY DISTRIBUTION CHANNEL

17.1 OVERVIEW

17.2 DIRECT TENDER

17.3 THIRD PARTY DISTRIBUTORS

17.4 OTHERS

18 U.S. DENTAL BONE GRAFT MARKET: COMPANY LANDSCAPE

18.1 MANUFACTURER COMPANY SHARE ANALYSIS: U.S.

19 SWOT ANALYSIS

20 COMPANY PROFILE

20.1 GEISTLICH PHARMA AG

20.1.1 COMPANY SNAPSHOT

20.1.2 PRODUCT PORTFOLIO

20.1.3 RECENT DEVELOPMENT

20.2 ZIMVIE INC.

20.2.1 COMPANY SNAPSHOT

20.2.2 PRODUCT PORTFOLIO

20.2.3 RECENT DEVELOPMENT

20.3 DENTSPLY SIRONA

20.3.1 COMPANY SNAPSHOT

20.3.2 REVENUE ANALYSIS

20.3.3 PRODUCT PORTFOLIO

20.3.4 RECENT DEVELOPMENT

20.4 ENVISTA

20.4.1 COMPANY SNAPSHOT

20.4.2 REVENUE ANALYSIS

20.4.3 PRODUCT PORTFOLIO

20.4.4 RECENT DEVELOPMENT

20.5 BIOHORIZONS (BRAND OF BIOHORIZONS CAMLOG GROUP)

20.5.1 COMPANY SNAPSHOT

20.5.2 PRODUCT PORTFOLIO

20.5.3 RECENT DEVELOPMENT

20.6 AUGMA BIOMATERIALS

20.6.1 COMPANY SNAPSHOT

20.6.2 PRODUCT PORTFOLIO

20.6.3 RECENT DEVELOPMENT

20.7 BOTISS BIOMATERIALS GMBH

20.7.1 COMPANY SNAPSHOT

20.7.2 PRODUCT PORTFOLIO

20.7.3 RECENT DEVELOPMENT

20.8 CURASAN AG

20.8.1 COMPANY SNAPSHOT

20.8.2 REVENUE ANALYSIS

20.8.3 PRODUCT PORTFOLIO

20.8.4 RECENT DEVELOPMENT

20.9 DENTIUM

20.9.1 COMPANY SNAPSHOT

20.9.2 PRODUCT PORTFOLIO

20.9.3 RECENT DEVELOPMENT

20.1 EVERGEN

20.10.1 COMPANY SNAPSHOT

20.10.2 PRODUCT PORTFOLIO

20.10.3 RECENT DEVELOPMENT

20.11 IMPLADENT LTD.

20.11.1 COMPANY SNAPSHOT

20.11.2 PRODUCT PORTFOLIO

20.11.3 RECENT DEVELOPMENT

20.12 KEYSTONE DENTAL GROUP

20.12.1 COMPANY SNAPSHOT

20.12.2 PRODUCT PORTFOLIO

20.12.3 RECENT DEVELOPMENT

20.13 LIFENET HEALTH

20.13.1 COMPANY SNAPSHOT

20.13.2 PRODUCT PORTFOLIO

20.13.3 RECENT DEVELOPMENT

20.14 MEGA’GEN IMPLANT CO., LTD.

20.14.1 COMPANY SNAPSHOT

20.14.2 PRODUCT PORTFOLIO

20.14.3 RECENT DEVELOPMENT

20.15 MTF BIOLOGICS

20.15.1 COMPANY SNAPSHOT

20.15.2 PRODUCT PORTFOLIO

20.15.3 RECENT DEVELOPMENT

20.16 NOVABONE

20.16.1 COMPANY SNAPSHOT

20.16.2 PRODUCT PORTFOLIO

20.16.3 RECENT DEVELOPMENT

20.17 ORTHOGEN LLC

20.17.1 COMPANY SNAPSHOT

20.17.2 PRODUCT PORTFOLIO

20.17.3 RECENT DEVELOPMENT

20.18 OSSTEM IMPLANT CO., LTD.

20.18.1 COMPANY SNAPSHOT

20.18.2 PRODUCT PORTFOLIO

20.18.3 RECENT DEVELOPMENT

20.19 PURGO BIOLOGICS INC

20.19.1 COMPANY SNAPSHOT

20.19.2 PRODUCT PORTFOLIO

20.19.3 RECENT DEVELOPMENT

20.2 REGENITY BIOSCIENCES

20.20.1 COMPANY SNAPSHOT

20.20.2 PRODUCT PORTFOLIO

20.20.3 RECENT DEVELOPMENT

20.21 SIGMAGRAFT BIOMATERIALS

20.21.1 COMPANY SNAPSHOT

20.21.2 PRODUCT PORTFOLIO

20.21.3 RECENT DEVELOPMENT

21 QUESTIONNAIRE

22 RELATED REPORTS